Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Provisional Agreement on EU Pharmaceutical Refo...
By
João L. Carapinha
December 12, 2025
Provisional Deal Ushers in EU Pharmaceutical Reform The European Parliament and Council have reached a provisional agreement to overhaul the EU's pharmaceutical policy framework, m...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicine...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chr...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
1
2
3
…
24
Next »